# Correction: Hybrid thiazolyl–benzylidene–phenol metal complexes as novel chemotherapeutic agents with anti-topoisomerase I activity in human breast carcinoma: synthesis, in vitro and in silico studies

## TL;DR

This paper corrects a previous study on new metal complexes that may help treat breast cancer by targeting an enzyme involved in DNA repair.

## Contribution

The paper provides a correction to prior research on the synthesis and testing of novel metal complexes for breast cancer treatment.

## Key findings

- The corrected study details the synthesis of hybrid thiazolyl–benzylidene–phenol metal complexes.
- These complexes show anti-topoisomerase I activity, which is relevant for cancer therapy.
- In vitro and in silico studies support their potential as chemotherapeutic agents.

## Abstract

Correction for ‘Hybrid thiazolyl–benzylidene–phenol metal complexes as novel chemotherapeutic agents with anti-topoisomerase I activity in human breast carcinoma: synthesis, in vitro and in silico studies’ by Ahmed M. Alharbi et al., RSC Adv., 2025, 15, 20552–20569, https://doi.org/10.1039/D5RA00889A.